David J Katzoff insider trades
Open-market stock purchases and sales by David J Katzoff, Chief Financial Officer at Alzamend Neuro, Inc, from SEC Form 4 filings since Sep 14, 2022.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +5%.
Recent trades
No open-market trades in the last 12 months.